Sivik Global Healthcare’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sivik Global Healthcare’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2M	Hold	150,000	–	–	14.55%	1
2026 Q1	$19.2M	Sell	150,000 -75,000	-33%	-$9.36M	14.55%	1
2025 Q4	$27.4M	Sell	225,000 -25,000	-10%	-$2.87M	7.96%	1
2025 Q3	$25.1M	Hold	250,000	–	–	7.29%	1
2025 Q2	$20.7M	Hold	250,000	–	–	5.64%	3
2025 Q1	$20.3M	Buy	250,000 +50,000	+25%	+$4.47M	10.96%	1
2024 Q4	$18M	Sell	200,000 -100,000	-33%	-$9.69M	9.48%	1
2024 Q3	$29.6M	Buy	+300,000	New	+$29.5M	12.55%	1
2024 Q2	–	Sell	-300,000	Closed	-$28.5M	–	51
2024 Q1	$28.5M	Buy	300,000 +164,412	+121%	+$15.3M	6.67%	2
2023 Q4	$12.1M	Buy	135,588 +35,588	+36%	+$2.64M	5.06%	1
2023 Q3	$7.3M	Sell	100,000 -150,000	-60%	-$12M	3.69%	11
2023 Q2	$20.8M	Buy	250,000 +50,000	+25%	+$4.18M	4.87%	2
2023 Q1	$15.2M	Buy	200,000 +25,000	+14%	+$2.07M	6.55%	1
2022 Q4	$14.5M	Buy	175,000 +163,716	+1,451%	+$13.3M	6.83%	1
2022 Q3	$895K	Sell	11,284 -38,716	-77%	-$3.26M	0.5%	40
2022 Q2	$3.71M	Sell	50,000 -100,000	-67%	-$7.51M	2.11%	25
2022 Q1	$13.5M	Buy	150,000 +50,000	+50%	+$4.62M	5.57%	1
2021 Q4	$11.2M	Buy	+100,000	New	+$12.1M	4.8%	1
2021 Q3	–	Sell	-100,000	Closed	-$13.5M	–	58
2021 Q2	$13.5M	Buy	+100,000	New	+$13.1M	2.64%	2
2019 Q1	–	Sell	-75,000	Closed	-$5.38M	–	66
2018 Q4	$5.38M	Buy	+75,000	New	+$6.04M	2.9%	14

Other funds holding XBI

PSP Research Newtown Square, Pennsylvania $188M AUM

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Sivik Global Healthcare's XBI Position: Q2 2026 in Review

Sivik Global Healthcare held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 150,000 shares worth $19.2M. The position accounts for 14.55% of the portfolio, ranked #1.

Sivik Global Healthcare first reported a position in XBI in Q4 2018 and has held it in 20 quarters since. The position peaked at $29.6M in Q3 2024. 321 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Sivik Global Healthcare held 150,000 shares of State Street SPDR S&P Biotech ETF worth $19.2M as of Q2 2026.
Sivik Global Healthcare left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 14.55% of Sivik Global Healthcare's portfolio in Q2 2026, its #1 holding.
Sivik Global Healthcare first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 20 quarters since.
Sivik Global Healthcare's State Street SPDR S&P Biotech ETF position peaked at $29.6M in Q3 2024.
321 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.